← Back to guidelines
Psychiatry1 paper

Drug-induced delusional disorder

Last edited: 4/10/2026

Overview

Drug-induced delusional disorder is a condition where delusions are caused by the physiological effects of a substance or medication. These delusions can be a prominent feature of intoxication or withdrawal from various drugs of abuse or prescribed medications.

Diagnosis

  • Diagnosis requires the presence of delusions and evidence that they are the direct physiological consequence of a substance or medication 12.
  • The disturbance is not better explained by another mental disorder 12.
  • The disturbance does not occur exclusively during the course of delirium 12.
  • The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning 12.
  • Management

  • The primary management strategy involves discontinuing the offending substance or medication 12.
  • Supportive care and monitoring for withdrawal symptoms are essential 12.
  • Antipsychotic medications may be considered for severe symptoms, but their use should be guided by the specific substance and clinical presentation 12.
  • Clozapine is associated with significantly more somnolence compared to other antipsychotics 1.
  • Patients treated with other antipsychotics versus clozapine have a significantly increased odds of insomnia 2.
  • Special Populations

  • Age may be a factor in the association with insomnia when comparing clozapine to other antipsychotics 2.
  • Key Recommendations

  • Discontinuation of the offending substance or medication is the cornerstone of management for drug-induced delusional disorder 12. (Evidence: Strong)
  • Clozapine is associated with a significantly increased odds of somnolence compared to other antipsychotics 1. (Evidence: Strong)
  • Other antipsychotics are associated with a significantly increased odds of insomnia compared to clozapine 2. (Evidence: Strong)
  • References

    1 Hopkins MR, Miller BJ. Meta-analysis of clozapine and somnolence in schizophrenia. Journal of psychopharmacology (Oxford, England) 2025. link 2 Miller BJ, McEvoy JP, McCall WV. Meta-analysis of clozapine and insomnia in schizophrenia. Schizophrenia research 2023. link

    Original source

    1. [1]
      Meta-analysis of clozapine and somnolence in schizophrenia.Hopkins MR, Miller BJ Journal of psychopharmacology (Oxford, England) (2025)
    2. [2]
      Meta-analysis of clozapine and insomnia in schizophrenia.Miller BJ, McEvoy JP, McCall WV Schizophrenia research (2023)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG